Jord BioScience
PrivateLast Round
Series B
Feb 19, 2025
Total Funding Raised
$9.1M
Company Overview
Jord BioScience is a biotechnology company that develops customizable microbial solutions to enhance crop health, productivity, and sustainability in the agricultural industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jord BioScience Comparables
Compare Jord BioScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Switch Bioworks | 81% | |
| Kula Bio | 80% | |
| Zymofix | 77% | |
Jord BioScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 19, 2025 |
Jord BioScience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Direct Investment Venture Capital Program | Series B |
| Discovery Capital Funding | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2025
Rob DeWolfe appointed Chief Financial and Operating Officer.
- Feb 19, 2025
$7M round completed.
Jord BioScience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Jord BioScience's valuation, stock price, and market status.